SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?


To: phoenix_rising who wrote (1272)6/4/2015 9:57:51 AM
From: eico20  Read Replies (1) | Respond to of 2026
 
good find, not a well researched article IMO, Welbutrin is being given off label for HSDD and it has the same side effects but more severe, and alcohol effects many drugs and the labeling for that is inconsistent, Sprout is proposing a good warning label, if the drug is taken at bedtime, the alcohol issue is greatly reduced,
Sprout is doing a good job so far